Percutaneous Transluminal Angioplasty

From WikiLectures

thumb|260px|Princip PTCA thumb|250px|Selektivní angiografie a. renalis po proběhlé PTRA Percutaneous Transluminal Angioplasty (PTA) is an invasive treatment where we use a special balloon catheter, an occluded blood vessel is penetrated through behind the stenosis. The occluded blood vessel is then mechanically dilated using the balloon. After the dilatation happened, there might be also stent implantation or stentgraft (stenting) implantation. The most common causes of blood vessel stenosis are aterosclerosis, fibromuscular dysplasia, status post recurrent vessel traumas, et cetera.

PTA is used in case of stenosis in extremity artery, renal artery (PTRA, percutaneous transluminal renal angioplasty), coronary artery (PTCA, percutaneous transluminal coronary angioplasty), supraaortal arteries. PTA can be also used in case of a major vein stenosis or A-V shunt stenosis in dialyzed patients.

Indication[edit | edit source]

PTA is generally indicated for short circular stenoses.

  • Extremity arteriesICHDK type II.B – IV, to improve blood circulation before planned bypass, bypass stenosis.
  • Supraaortal arteries – symptoms are ischemia of upper extremities and brain (stenosis aa. caroticae, vertebrobasilar insufficiency).
  • PTRArenovascular hypertension caused by aterosclerosis or fibromuscular dysplasia.
  • PTCA – stable angina pectoris non responding to therapy, unstable angina pectoris, ACS, stenosis of bypass connecting aorta and coronary arteries.
  • Veins – stenosis of dialyzation shunt, vena cava superior syndrome.

Contraindications[edit | edit source]

There are contraindications divided to absolute and relative:

  1. absolute – unstable patient, hemodynamically major stenosis, pro-bleeding state;
  2. relative – stenosis is too major.

Technique[edit | edit source]

  1. Blood coagulation parameters (INR, APTT, thrombocytes count).
  2. Antiagregans prior to the surgery is given (Template:HVLP, Template:HVLP) and calcium channel blocker (Template:HVLP – vasopasm prevention).
  3. Prevention of anaphylaxis in case of adverse allergic reaction to contrasting color (antihistamines, corticosteroids).
  4. Vessel puncture (mainly a. femoralis).
  5. Heparin administration.
  6. View of the affected vessel area, insertion of the leading wire and via the wire the catheter is inserted.
  7. Balloon insuflation, laesion dilatation (balloon has to stay at least 1-2 minutes inflated).
  8. Control angiography.
  9. Post surgery continual administration of heparin s.c. for two days, min. 6 months post surgery antiagregans (acid acetylsalicylic, Anopyrin®).

Complications[edit | edit source]

  • Central (contrasting color) – anaphylaxis, renal failure.
  • In puncture location – hematoma, pseudoaneurysm, arteriovenous fistula.
  • In PTA location – dissection, spasm, peripheral embolization, vessel rupture is extremely rare.

Odkazy[edit | edit source]

Související články[edit | edit source]

Zdroj[edit | edit source]

Použitá literatura[edit | edit source]


Kategorie:Vložené články Kategorie:Chirurgie Kategorie:Kardiologie Kategorie:Angiologie Kategorie:Vnitřní lékařství Kategorie:Radiodiagnostika